Epilepsy is a neurological disorder that is characterised by recurrent seizures and affects about 50 million people worldwide. While pharmaceuticals have historically been the primary treatment approach, the landscape of epilepsy management is evolving with the emergence of promising technologies such as neuromodulation devices. GlobalData’s latest models forecast consistent growth for these devices in the near future.
